Date Range
toReport Types
Condition
See all (12)
Region of the Body
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Titrated THC and CBD does not significantly improve spasticity compared to placebo over 4 weeks
J Neurol. 2015 Nov;262(11):2520-7
THC/CBD oromucosal spray is not better than placebo for diabetic neuropathy over 12 weeks
Diabetes Care. 2010 ;33(1):128-130. http://dx.doi.org/10.2337/dc09-1029
Cannabis medicinal extract effective in improving some neurogenic symptoms - a pilot study
Clin Rehabil. 2003 Feb;17(1):21-9.
Nabiximol effective and safe in managing spasticity in patients with refractory MS
Neurol Res. 2010 Jun;32(5):451-9. doi: 10.1179/016164109X12590518685660
Titrated THC:CBD Improves Pain and Spasticity Compared to Placebo Over 12 Weeks for Resistant MS
Int J Neurosci. 2018 Sep 13:1-10.
Cannabis-based medicinal extracts effective in managing spasticity, but not other symptoms of MS
Mult Scler. 2004 Aug;10(4):434-41.
Sativex effective in alleviating pain and allodynia from neuropathy after 5-week follow up
Pain. 2007 Dec 15;133(1-3):210-20
Oral THC/CBD spray provides neuropathic pain control in MS patients, with mild/moderate side effects
Clin Ther. 2007 Sep;29(9):2068-79
Comparing THC, CBD, 1:1 mixture of THC:CBD, and placebo in management of patients with chronic pain
Anaesthesia. 2004 May;59(5):440-52
Synthetic CBD for Psoriatic Arthritis and Hand Osteoarthritis
Pain. 2022 01-Jun;():. 10.1097/j.pain.0000000000002466
CBD 600mg Normalizes Neuroendocrine and Anxiety Responses to Stress in Patients at Risk of Psychosis
Psychopharmacology. 2020 ;():. 10.1007/s00213-019-05442-6
Oral Cannabidiol Does Not Reduce Acute Non-traumatic Low Back Pain
Med J Aust. 2021 01-May;():. 10.5694/mja2.51014
Efficacy of a cannabis-based oromucosal spray in managing peripheral neuropathic pain
Eur J Pain. 2014 Aug;18(7):999-1012. doi: 10.1002/j.1532-2149.2013.00445.x
Buccally Absorbed Cannabidiol for Pain Control After Arthroscopic Rotator Cuff Repair
Am J Sports Med. 2022 01-Jul;():. 10.1177/03635465221109573
Cannabis oromucosal spray slightly decreases neuropathic pain from brachial plexus injury
Pain. 2004;(3):299-306.
Cannabis oralmucosal spray does not significantly improve neuropathic pain from multiple sclerosis
J Neurol. 2013 Apr;260(4):984-97. doi: 10.1007/s00415-012-6739-4
Efficacy of a cannabis-based oromucosal spray in managing pain of rheumatoid arthritis
Rheumatology (Oxford, England). 2006;(1):Feb-50.
Oromucosal route of delivering cannabis based medicine safe and effective in pain reduction
Neurology. 2005 Sep 27;65(6):812-9
Nabiximols improves multiple sclerosis spasticity compared to placebo over 12 weeks
Eur J Neurol. 2011 Sep;18(9):1122-31. doi: 10.1111/j.1468-1331.2010.03328.x